Chang M H, Hsu H Y, Hsu H C, Ni Y H, Chen J S, Chen D S
Department of Pediatrics, College of Medicine, National Taiwan University, Taipei.
Hepatology. 1995 Nov;22(5):1387-92.
To investigate the significance of spontaneous hepatitis B e antigen (HBeAg) seroconversion during childhood, 415 hepatitis B surface antigen (HBsAg) carrier children (ages 0 to 15 years) were prospectively followed for 7.1 +/- 2.9 years. Hepatitis B virus (HBV) markers and liver function profiles of each child were tested at least once every 6 months. Among them, 50 were initially anti-HBe positive and 140 seroconverted from HBeAg to anti-HBe during follow-up. Before HBeAg seroconversion, jaundice occurred in 9 and alanine transaminase (ALT) activities elevated in 99 of the 140 seroconverters. Serum ALT returned to normal in all patients within 1 to 5 years of seroconversion. Six had reelevated ALT later after seroconversion. Only 7 (9.7%) of the 72 carrier infants seroconverted before 3 years of age. The peak ALT levels in five of them exceeded 100 IU/L, and two had jaundice before HBeAg seroconversion. One of the early seroconverters developed hepatocellular carcinoma (HCC) at 11 years of age, although his liver function profiles remained normal after HBeAg seroconversion. Liver biopsy specimens from 30 children during the anti-HBe-positive stag e showed inactive cirrhosis in 2 (including one with HCC), chronic hepatitis with marked fibrosis in 1, mild activity and moderate fibrosis in 2, mild activity and mild fibrosis in 9, and minimal histologic changes in the remaining 16. Although most will achieve a normalization of ALT and inactive liver histologic changes, the seroconversion of HBsAg carrier children from HBeAg to anti-HBe is not necessarily an indicator of favorable prognosis; a small proportion of children will develop cirrhosis or even HCC.
为研究儿童期自发性乙肝e抗原(HBeAg)血清学转换的意义,对415例乙肝表面抗原(HBsAg)携带儿童(年龄0至15岁)进行了7.1±2.9年的前瞻性随访。每位儿童的乙肝病毒(HBV)标志物和肝功能指标至少每6个月检测一次。其中,50例最初抗-HBe阳性,140例在随访期间从HBeAg血清学转换为抗-HBe。在HBeAg血清学转换前,140例血清学转换者中有9例出现黄疸,99例丙氨酸转氨酶(ALT)活性升高。血清ALT在血清学转换后1至5年内均恢复正常。6例在血清学转换后ALT后来再次升高。72例携带婴儿中只有7例(9.7%)在3岁前发生血清学转换。其中5例的ALT峰值水平超过100 IU/L,2例在HBeAg血清学转换前出现黄疸。1例早期血清学转换者在11岁时发生肝细胞癌(HCC),尽管其HBeAg血清学转换后肝功能指标仍保持正常。30例处于抗-HBe阳性阶段儿童的肝活检标本显示,2例有静止性肝硬化(其中1例合并HCC),1例为慢性肝炎伴显著纤维化,2例为轻度活动伴中度纤维化,9例为轻度活动伴轻度纤维化,其余16例组织学改变轻微。虽然大多数儿童的ALT会恢复正常且肝脏组织学改变不活跃,但HBsAg携带儿童从HBeAg血清学转换为抗-HBe不一定是预后良好的指标;一小部分儿童会发展为肝硬化甚至HCC。